INDUCTION OF RAT HEPATIC MIXED-FUNCTION OXIDASES BY ACETONE AND OTHER PHYSIOLOGICAL KETONES - THEIR ROLE IN DIABETES-INDUCED CHANGES IN CYTOCHROME P450 PROTEINS

被引:31
作者
BARNETT, CR
PETRIDES, L
WILSON, J
FLATT, PR
IOANNIDES, C
机构
[1] UNIV SURREY,SCH BIOL SCI,DIV TOXICOL,MOLEC TOXICOL GRP,GUILDFORD GU2 5XH,SURREY,ENGLAND
[2] UNIV ULSTER,BIOMED SCI RES CTR,COLERAINE,LONDONDERRY BT5,NORTH IRELAND
[3] UNIV ULSTER,DEPT BIOL & BIOMED SCI,COLERAINE,LONDONDERRY BT5,NORTH IRELAND
关键词
D O I
10.3109/00498259209056694
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. To evaluate the role of ketone bodies in diabetes-induced changes in hepatic cytochrome P450 composition, rats were treated with acetone, 3-hydroxybutyrate or 1,3-butanediol. 2. Treatment with acetone enhanced the rat hepatic 0-dealkylations of ethoxyresorufin and methoxyresorufin, and the hydroxylation of p-nitrophenol, but had no effect on lauric acid hydroxylation and ethylmorphine N-demethylation. Neither 3-hydroxybutyrate nor 1,3-butanediol modulated the metabolism of the above substrates. 3. Immunoblot analysis of hepatic microsomal proteins revealed that treatment with acetone increased the apoprotein levels of P4501A2, P4502B1/2 and P4502E1. 4. It is concluded that acetone is responsible, at least partly, for the diabetes-induced increase in hepatic microsomal P4501A2, P4502B1/2 and P4502E1 proteins but does not mediate the increases in the P4503A1 and P4504A1 proteins. On the basis of work from our own and other laboratories a mechanism for the diabetes-induced changes in hepatic cytochrome P450 proteins is proposed.
引用
收藏
页码:1441 / 1450
页数:10
相关论文
共 50 条
[1]   INDUCTION OF THE CYTOCHROME-P450 I-FAMILY AND IV-FAMILY AND PEROXISOMAL PROLIFERATION IN THE LIVER OF RATS TREATED WITH BENOXAPROFEN - POSSIBLE IMPLICATIONS IN ITS HEPATOTOXICITY [J].
AYRTON, AD ;
IOANNIDES, C ;
PARKE, DV .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (01) :109-115
[2]   INDUCTION OF CYTOCHROME-P450III AND CYTOCHROME-P450IV FAMILY PROTEINS IN STREPTOZOTOCIN-INDUCED DIABETES [J].
BARNETT, CR ;
GIBSON, GG ;
WOLF, CR ;
FLATT, PR ;
IOANNIDES, C .
BIOCHEMICAL JOURNAL, 1990, 268 (03) :765-769
[3]   ROLE OF KETONE-BODIES IN THE DIABETES-INDUCED CHANGES IN HEPATIC MIXED-FUNCTION OXIDASE ACTIVITIES [J].
BARNETT, CR ;
FLATT, PR ;
IOANNIDES, C .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 967 (02) :250-254
[4]   HYPERKETONEMIA MARKEDLY MODULATES THE METABOLIC-ACTIVATION OF CHEMICAL CARCINOGENS [J].
BARNETT, CR ;
FLATT, PR ;
IOANNIDES, C .
CHEMICO-BIOLOGICAL INTERACTIONS, 1990, 74 (03) :281-289
[5]   INDUCTION OF HEPATIC MICROSOMAL-P450-I AND MICROSOMAL-P450-IIB PROTEINS BY HYPERKETONEMIA [J].
BARNETT, CR ;
FLATT, PR ;
IOANNIDES, C .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (02) :393-397
[6]  
BELLWARD GD, 1988, MOL PHARMACOL, V33, P140
[7]  
BURKE MD, 1974, DRUG METAB DISPOS, V2, P583
[8]   ALTERATIONS IN HEPATIC MONODEIODINATION OF IODOTHYRONINES IN THE DIABETIC RAT [J].
CHOPRA, IJ ;
WIERSINGA, W ;
FRANK, H .
LIFE SCIENCES, 1981, 28 (15-1) :1765-1776
[9]   HYPERLIPIDEMIA IN DIABETES-MELLITUS [J].
DUNN, FL .
DIABETES-METABOLISM REVIEWS, 1990, 6 (01) :47-61
[10]   CYTOCHROME-P-450 ALTERATIONS IN THE BB/WOR SPONTANEOUSLY DIABETIC RAT [J].
FAVREAU, LV ;
SCHENKMAN, JB .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (18) :3505-3509